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Abstract
Background: The prevalence of type 2 diabetes mellitus (T2DM) varies signiﬁcantly across ethnic groups. A better
understanding of the mechanisms underlying the variation in different ethnic groups may help to elucidate the
pathophysiology of T2DM. The present work aims to generate a hypothesis regarding “why do subjects with African
background have excess burden of T2DM?”.
Methods: In the current study, we performed metabolite proﬁling of plasma samples derived from 773 subjects of
three ethnic groups (Dutch with European, Ghanaian and African Surinamese background). We performed Bayesian
lognormal regression analyses to assess associations between HbA1c and circulating metabolites.
Results: Here we show that subjects with African Surinamese and Ghanaian background had similar associations of
HbA1c with circulating amino acids and triglyceride-rich lipoproteins as subjects with European background. In
contrast, subjects with Ghanaian and African Surinamese background had different associations of HbA1c with
acetoacetate, small LDL particle and small HDL particle concentrations, compared to the subjects with European
background.
Conclusions: On the basis of the observations, we hypothesize that the excess burden of T2DM in subjects with
African background may be due to impaired cholesterol efﬂux capacity or abnormal cholesterol uptake.
Introduction
The prevalence of type 2 diabetes mellitus (T2DM)
increased rapidly worldwide during the past decades, and
is strongly associated with the developing obesity pan-
demic1. Apart from the common risk factors that prevail
in all populations, ethnic background is a risk factor as
well2. In the Netherlands, subjects with a migration
background showed a considerable higher incidence of
T2DM compared to subjects with European back-
ground3,4. Among men, individuals with European, Gha-
naian and African Surinamese background had T2DM
prevalence of 5.0, 14.9 and 10.4%, respectively5. Among
women, the prevalence is 2.3% (European), 11.1% (Gha-
naian) and 11.5% (African Surinamese)5. Interestingly, the
differences in T2DM prevalence across ethnic groups
could not be explained by genetic variants or dietary
pattern alone6,7. In contrast, other studies showed that the
ethnic differences in T2DM prevalence were accompanied
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by differences in plasma amino acids and lipids. In line
with this, compared to Europeans, the serum concentra-
tions of isoleucine, phenylalanine, tyrosine and alanine
were signiﬁcantly higher in South Asians8. In another
study9, individuals with Surinamese background were
identiﬁed to have lower sphingolipids, but higher unsa-
turated acylcarnitines and higher amino acid levels, than
Europeans.
Metabolite proﬁling, or metabolomics, has been widely
applied to identify new biomarkers for T2DM10,11, predict
T2DM risk12,13 and improve our understanding of
pathophysiologic mechanisms14,15. The most frequently
observed metabolic abnormalities in insulin resistant and
T2DM subjects include elevated circulating branched
amino acids (BCAAs) and aromatic amino acids
(AAAs)16–18. A hypothesized mechanism linking elevated
BCAAs to T2DM is that disturbed BCAA metabolism
leads to accumulation of BCAA metabolites (e.g. 2-
Aminoadipic acid), resulting in pancreatic β cell dys-
function19,20. High triglyceride and low HDL cholesterol
is another frequently observed metabolic abnormality in
insulin resistance and T2DM subjects21–25. Often dysli-
pidemias are viewed as consequences rather than cause of
T2DM21–23. However, cholesterol homeostasis plays an
important role in regulating pancreatic β cell function26–28.
Cholesterol is taken up by pancreatic β cells via the LDL
receptor and exported back to plasma via the
ATP-binding cassette transporter A1 (ABCA1)29. Accu-
mulation of cholesterol in pancreatic β cells leads to
impairment of glucose tolerance and defective insulin
secretion26,28,29.
The present work aimed to generate a hypothesis
regarding “why do subjects with African background have
excess burden of T2DM?”. As an initial step, we investi-
gated whether the relationship between circulating
metabolites and glucose tolerance varies depending on
ethnicity. Regarding circulating metabolites, we focused
on amino acids, ketone bodies and lipoproteins, similar to
what has been reported in other studies on glyce-
mia17,21,30,31. In this study, we used the hemoglobin A1C
(HbA1c) level as the surrogate of glucose tolerance, since
HbA1c is an index of chronic glycemia and a predictor of
T2DM32,33. Regarding ethnicity, we focused on Dutch
with European, Ghanaian and African Surinamese back-
ground and described associations between HbA1c with
amino acids, ketone bodies and lipoproteins in all three
ethnic groups. The results of the association analyses fuel
our hypothesis regarding “why do subjects with African
background have an excess burden of T2DM?”.
Materials and Methods
Study population
The study population was composed of three ethnic
groups in the Dutch population. In particular, 217 African
Surinamese and 255 Ghanaian were from the HELIUS
(HEalthy Life In an Urban Setting) study34,35, and 301
European Dutch were from the 300-Obesity cohort36
from the Human Functional Genomics Project37.
HELIUS is a multiethnic prospective cohort study in
Amsterdam, the Netherlands. Participants of HELIUS
study (18–70 years old) were randomly sampled and
stratiﬁed by ethnic origin through the municipal registry
of Amsterdam between 2011 and 2015. A total of 25 000
participants were included at baseline. In this study,
252 subjects (99 with Ghanaian background and 153 with
African Surinamese background) had diabetes. The other
220 (156 with Ghanaian background and 64 with African
Surinamese background) had prediabetes and were ran-
domly sampled from the corresponding ethnic groups.
All participants enrolled in the 300-Obesity cohort
study had a BMI above 27 kg/m2. The exclusion criteria
include a recent cardiovascular event (myocardial infarc-
tion, transient ischemic attack, stroke in the past
6 months), a history of bariatric surgery or bowel resec-
tion, inﬂammatory bowel disease, renal dysfunction or
increased bleeding tendency, and using oral or sub-
cutaneous anticoagulant therapy or thrombocyte aggre-
gation inhibitors (other than acetylsalicylic acid and
carbasalate calcium).
In both the HELIUS and 300-Obesity cohort study,
participants were considered to have diabetes if: 1. Fasting
glucose level was >7 mmol/L. 2. if a participant was using
glucose-lowering medication. 3. if a participant self-
reported to have been diagnosed with diabetes by a
health care professional.
The criterion for prediabetes was fasting glucose
>5 mmol/l or HbA1c above 5.7%.
Both studies complied with all relevant ethical regula-
tions and in accordance with the Declaration of Helsinki
(6th, 7th revisions), and all participants provided written
informed consent. HELIUS and the 300-Obesity studies
were approved by the Ethics Committee in Academic
Medical Center (AMC) Medical and Radboud university
medical center.
HbA1c measurement
Whole blood samples were used to determine the
concentration of HbA1c using HPLC technology
(TOSOH, Tokyo, Japan).
Metabolite proﬁling
Fasting plasma samples were collected in the clinic and
stored at −80 °C. Quantiﬁcation of 8 amino acids, 2
ketone bodies and 14 lipoproteins was performed by using
a high-throughput NMR metabolomics platform (Night-
ingale, Austria)38. The following 14 lipoprotein subclasses
were quantiﬁed: extremely large (average particle dia-
meter >75 nm), very large (average particle diameter
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64.0 nm), large (53.6 nm), medium (44.5 nm), small
(36.8 nm) and very small VLDL (31.3 nm); intermediate-
density lipoprotein (IDL; 28.6 nm); three LDL subclasses,
i.e. large (25.5 nm), medium (23.0 nm) and small LDL
(18.7 nm); and four HDL subclasses, i.e. very large
(14.3 nm), large (12.1 nm), medium (10.9 nm) and small
HDL (8.7 nm).
Statistical analysis
Because this study contains three ethnic groups from
two different cohort studies with different time of sam-
pling and measurement, we cannot directly compare
metabolite variables between ethnic groups. As an alter-
native, we performed association analyses between HbA1c
and circulating metabolites within each ethnic group. The
outcome variable (y) was concentration of a metabolite,
such as amino acids, ketone bodies, or lipoprotein parti-
cles. The predictor variable (x) was the HbA1c
concentration.
To assess the strength of associations between HbA1c
and metabolites, we ran lognormal regression because the
outcome variables are positive continuous data with skewed
distributions. To study the dependency of ethnicity on the
relationship between HbA1c and metabolic variables, we
introduced ethnicity-speciﬁc intercepts and slopes into the
model. We also adjusted for covariates including gender,
age, diabetic status and BMI (body mass index). We cen-
tered and scaled HbA1c, age and BMI, so that one unit
HbA1c means 10mmol/mol, one unit age means 10 (years),
and one unit BMI means 5 kg/m2. Due to missing obser-
vations in both outcome and predictor variables, we applied
a Bayesian lognormal regression to handle the missing data.
There are two types of missing values, which are as follows:
(1) when the concentration of a metabolite is below the
limit of detection, or (2) when values were rejected by the
automatic sample and measurement quality control pro-
cedure in the Nightingale pipeline. All the missing obser-
vations were assumed missing at random and treated as
parameters. Values were randomly drawn from a normal
distribution with ethnicity-dependent mean and standard
deviation. Based on a previous study39 the mean value and
standard deviation of HbA1c is about 40mmol/mol and
5mmol/mol, therefore, we used exponential (0.025) and
exponential (0.2) as prior distributions. In the same study,
the mean value and standard deviation of BMI is about
27 kg/m2 and 5 kg/m2, therefore, we used exponential (0.04)
and exponential (0.2) as prior distributions. Regarding the
missing values that were below the limit of detection, the
imputed values were constrained between zero and the
minimal observed value. For the other parameters, we used
regularizing prior distributions and ﬁtted the model by
running Hamiltonian Markov Chain Monte Carlo in the
program Stan (version 2.18.0)40. We ran four Markov
chains with 2000 iterations in each chain. Results were
presented with the posterior mean of lognormal regression
coefﬁcient with 95% credible interval (CI). The lognormal
regression coefﬁcient can be interpreted as the proportional
increase of the metabolite concentration as a result of a
change of 10mmol/mol HbA1c.
Result
Participant characteristics
This study included in total 773 subjects from three
ethnic groups in the Dutch population. Speciﬁcally, the
study population consisted of 301 European Dutch, 255
Dutch with Ghanaian background, and 217 Dutch with
African Surinamese background (Table 1). Dutch with
European background were older than the other two
ethnic groups. There were relatively more male partici-
pants in the Dutch with European background, and in the
Dutch with African Surinamese background, there were
relatively more female participants. In addition, 12.6% of
the participants with European background were diabetic,
whereas the proportion of diabetes in subjects with Afri-
can Surinamese and Ghanaian were 70.5 and 38.8%,
respectively. To control for these possible confounding
factors, all the results shown below were after adjusting
for gender, age, BMI and diabetic status. All association
statistics were provided in the supplementary Table S1,
Table S2, Table S3 and Table S4.
Table 1 Characteristics of 773 participants with different ethnic backgrounds
European (N= 301) Ghanaian (N= 255) African Surinamese (N= 217) P value
Female (%) 44.5 52.5 65.9 <0.0001
Age (years) 67.1 ± 5.4 51.2 ± 8.3 55.2 ± 7.2 <0.0001
BMI 30.7 ± 3.5 29.6 ± 4.4 31.2 ± 5.8 <0.0001
Waist circumference (cm) 107.0 ± 9.8 98.5 ± 10.6 103 ± 13.4 <0.0001
HbA1c (mmol/mol) 41.7 ± 7.9 56.1 ± 19.7 46.6 ± 15.4 <0.0001
Diabetes (%) 38 (12.6) 99 (38.8) 153 (70.5) <0.0001
Kruskal–Wallis test was used to calculate P values for age, BMI, waist circumference and HbA1c
χ2 test was used to calculate P values for gender and diabetes
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Association of HbA1c with circulating amino acids
Since circulating amino acids are robust markers of
T2DM, we ﬁrst evaluated their associations with HbA1c
in Dutch with European, African Surinamese and Gha-
naian background.
We observed that in prediabetic subjects with European
background, increasing HbA1c concentrations were
associated with increasing concentrations of circulating
isoleucine (regression coefﬁcient in males 0.14 with 95%
credible interval [0.07–0.19], in females 0.15 [0.09–0.21]),
leucine (males 0.06 [0.02–0.09], females 0.06 [0.02–0.09]),
valine (males 0.06 [0.02–0.10], females 0.06 [0.02–0.11]),
tyrosine (males 0.05 [0.01–0.10], females 0.05
[0.01–0.10]), and alanine (males 0.10 [0.05–0.14], females
0.11 [0.06–0.15]) (Fig. 1). Compared to prediabetic sub-
jects with European background, smaller associations
Fig. 1 Regression parameter estimates between plasma amino acids and HbA1c in subjects with European, Ghanaian and African
Surinamese background. Circles (female) or triangles (male) and horizontal lines represent the posterior means of the regression coefﬁcient
between plasma amino acids and HbA1c and 95% credible intervals
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between HbA1c and circulating isoleucine (males 0.09
[0.04–0.13], females 0.10 [0.05–0.15]), leucine (males 0.03
[0.005–0.06], females 0.03 [0.005–0.07]), and valine
(males 0.03 [0.001–0.07], females 0.04 [0.004–0.07]) were
observed in diabetic subjects with European background
(Fig. 1).
Similar to prediabetic subjects with European back-
ground, we observed that increasing concentrations of
HbA1c were associated with increasing concentrations of
isoleucine (0.07 [0.02–0.13]), leucine (0.03 [0.004–0.07]),
valine (0.04 [0.004–0.08]) and alanine (0.06 [0.02–0.10])
in prediabetic females with African Surinamese back-
ground, as well as in prediabetic females with Ghanaian
background (isoleucine 0.06 [0.005–0.11] and alanine 0.06
[0.02–0.10]). In diabetic females with African Surinamese
background, we observed that isoleucine (0.02
[0.001–0.05]) and valine (0.02 [0.004–0.04]) remained
their associations with HbA1c. Most interestingly, we
observed that increasing concentrations of HbA1c were
associated with decreasing concentrations of tyrosine in
diabetic females with African Surinamese background
(−0.02 [−0.03 to −0.001]) (Fig. 1).
Association of HbA1c with circulating ketone bodies
After circulating amino acids, ketone bodies were the
second group of metabolites that we analyzed. We
observed that increasing concentrations of HbA1c were
associated with decreasing concentrations of acetoacetate
in prediabetic subjects with European background (males
−0.29 [−0.44 to −0.14], females −0.34 [−0.49 to −0.18]),
but not in people with African background. Meanwhile,
we observed that increasing concentrations of HbA1c
were associated with decreasing concentrations of 3-
hydroxybutyrate in prediabetic subjects with Ghanaian
background (males −0.63 [−1.14 to −0.129], females
−0.62 [−1.14 to −0.112]), but not in people with Eur-
opean or African Surinamese background (Fig. 2).
Among diabetic subjects, we observed that increasing
concentrations of HbA1c were associated with decreasing
concentrations of acetoacetate in those with European
background (males −0.13 [−0.24 to −0.004], females
−0.17 [−0.30 to −0.05]), but were associated with
increasing concentrations of acetoacetate in African Sur-
inamese men (0.09 [0.02–0.17]) as well as subjects with
Ghanaian background (males 0.13 [0.05–0.20], females
0.08 [0.01–0.154]) (Fig. 2).
Association of HbA1c with circulating lipoproteins
Fourteen lipoproteins (4 apolipoprotein A1 and 10
apolipoprotein B containing lipoproteins) were the third
group of metabolites that we analyzed for their relation
with HbA1c.
Apolipoprotein A1 containing lipoproteins
Four apolipoprotein A1 containing lipoproteins (very
large, large, medium and small HDL particles) were
measured in the Nightingale metabolomics platform.
Here we observed that increasing concentrations of
HbA1c were associated with decreasing concentrations of
large HDL particles in prediabetic subjects with European
background (males −0.20 [−0.28 to −0.11], females
−0.17 [−0.26 to −0.08]), but not in prediabetic subjects
with African Surinamese and Ghanaian background. In
contrast to absence of associations in prediabetic subjects
with European background, we noticed that increasing
concentrations of HbA1c were associated with increasing
Fig. 2 Regression parameter estimates between plasma ketone bodies and HbA1c in subjects with European, Ghanaian and African
Surinamese background. Circles (female) or triangles (male) and horizontal lines represent the posterior means of the regression coefﬁcient
between plasma ketone bodies and HbA1c and 95% credible intervals
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concentrations of small HDL particles in prediabetic
subjects with African Surinamese background (males 0.03
[0.01–0.05], females 0.03 [0.01–0.05]) as well as in pre-
diabetic females with Ghanaian background (0.02
[0.0003–0.04]) (Fig. 3).
Similar to prediabetic subjects, we observed that
increasing concentrations of HbA1c were associated with
decreasing concentrations of large HDL particles (males
−0.13 [−0.21 to −0.06], females −0.11 [−0.19 to −0.04])
only in diabetic subjects with European background.
Furthermore, we observed that increasing concentrations
of HbA1c were associated with decreasing concentrations
of small HDL particles in diabetic subjects with European
background (males −0.02 [−0.04 to −0.004], females
−0.02 [−0.04 to −0.003]), but were associated with
increasing concentrations of small HDL particles in dia-
betic females with African Surinamese background (0.01
[0.001–0.02]) (Fig. 3).
Apolipoprotein B containing lipoproteins
Triglyceride-rich lipoproteins Triglyceride-rich lipo-
proteins, ranging from extremely large to very small
VLDL particles, showed similar patterns of associations
with HbA1c in prediabetic subjects with European,
African Surinamese and Ghanaian background. In all
three ethnic backgrounds, we observed that increasing
concentrations of HbA1c were associated with increasing
concentrations of large VLDL particles (Fig. 4).
In diabetic subjects, the association of HbA1c with
triglyceride-rich lipoproteins was smaller compared to
prediabetic subjects. We observed that increasing con-
centrations of extremely large VLDL remained associated
with increasing of HbA1c in diabetic subjects with
European background (males 0.47 [0.19–0.76], females
0.46 [0.16–0.74]) (Fig. 4).
Cholesterol-rich lipoproteins Cholesterol-rich lipopro-
teins including IDL, large, medium and small LDL
particles were not associated with HbA1c in prediabetic
subjects with European, African Surinamese and Gha-
naian background. However, in diabetic, subjects HbA1c
tended to positively correlate with concentrations of these
cholesterol-rich lipoproteins. In particular, we noticed
that increasing concentrations of HbA1c were associated
with increasing concentrations of small LDL particles in
diabetic subjects with African Surinamese (males 0.06
Fig. 3 Regression parameter estimates between plasma HDL particle concentration and HbA1c in subjects with European, Ghanaian and
African Surinamese background. Circles (female) or triangles (male) and horizontal lines represent the posterior means of the regression coefﬁcient
between plasma HDL particle concentration and HbA1c and 95% credible intervals
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[0.02–0.10], females 0.05 [0.02–0.08]) and Ghanaian
(males 0.06 [0.03–0.10], females 0.05 [0.01–0.09]) back-
ground, but were not associated with small LDL particle
concentrations in diabetic subjects with European back-
ground (Fig. 5).
Discussion
Why do subjects with African background have excess
burden of T2DM? As an initial step to address this
question, we performed metabolite proﬁling in plasma of
773 subjects from three ethnic groups in the Dutch
population (European, Ghanaian and African Surinamese
background), and assessed the associations of HbA1c with
metabolic proﬁles.
We started our analyses with associations between
HbA1c and circulating amino acids, because amino acids
such as BCAAs and AAAs are robust biomarkers for
prediabetes and diabetes11. Similar to other studies, we
observed that increasing concentrations of HbA1c were
associated with increasing concentrations of BCAAs
(isoleucine, leucine and valine) as well as tyrosine in
prediabetic participants with European background.
Compared to prediabetic subjects with European back-
ground, we observed that associations between HbA1c
and BCAAs were attenuated in diabetic subjects with
European background. This attenuation might be attri-
butable to medication or lifestyle changes.
Compared to participants with European background,
associations of HbA1c with circulating amino acids were
Fig. 4 Regression parameter estimates between plasma VLDL particle concentration and HbA1c in subjects with European, Ghanaian and
African Surinamese background. Circles (female) or triangles (male) and horizontal lines represent the posterior means of the regression coefﬁcient
between plasma VLDL particle concentration and HbA1c and 95% credible intervals
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similar but less strong in subjects with African Sur-
inamese and Ghanaian background. Interestingly, we
observed that increasing concentrations of HbA1c were
associated with decreasing concentrations of tyrosine in
African Surinamese women with diabetes, but were not
associated with this amino acid in diabetic participants
with European background. It is not clear why the asso-
ciation of HbA1c and tyrosine in diabetic women with
African Surinamese background was negative. Further
research is needed to understand the role of tyrosine
metabolism in hyperglycemia.
Overall, the less prominent associations between
HbA1c and circulating amino acids in subjects with
African background did not explain why they have excess
burden of T2DM compared to subjects with European
background. Therefore, we assumed that other metabolic
abnormalities may underlie the excess burden of T2DM
in subjects with African background.
In the next step, we evaluated associations of HbA1c
with circulating ketone bodies (acetoacetate and 3-
hydroxybutyrate). In our analysis, we observed that
increasing concentrations of HbA1c were associated with
decreasing concentrations of acetoacetate in diabetic
subjects with European background, but were associated
with increasing concentrations of acetoacetate in diabetic
subjects with Ghanaian background, as well as in diabetic
men with African Surinamese background. The effects of
ketone bodies on glucose metabolism is dependent on the
glucose level31. It was shown that elevation of circulating
ketone bodies stimulated insulin secretion in men when
high glucose was established41. This is in line with our
observation in diabetic subjects with European back-
ground. On the other hand, ketone bodies such as acet-
oacetate may also inhibit insulin secretion by suppressing
expression of ABCA1 (a key player in cellular cholesterol
efﬂux) and promote accumulation of intracellular cho-
lesterol42,43. We speculate that our observation of positive
associations between HbA1c and circulating acetoacetate
in African participants may be linked to the insufﬁcient
ABCA1-mediated cholesterol efﬂux capacity.
ABCA1-mediated cholesterol efﬂux exports intracel-
lular cholesterol to HDL particles. Therefore, we focused
on the associations of HbA1c levels and HDL particle
concentrations. Our observation that increasing HbA1c
correlated with decreasing large HDL particles in pre-
diabetic and diabetic subjects with European background
Fig. 5 Regression parameter estimates between plasma IDL and LDL particle concentration and HbA1c in subjects with European,
Ghanaian and African Surinamese background. Circles (female) or triangles (male) and horizontal lines represent the posterior means of the
regression coefﬁcient between plasma IDL and LDL particle concentration and HbA1c and 95% credible intervals
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was consistent with the notion that low circulating HDL
particle levels contribute to the pathophysiology of T2DM
and HDL elevation is a potential treatment for hypergly-
cemia44. However, in prediabetic subjects with African
Surinamese (men and women) and Ghanaian (women)
background, we observed that increasing concentrations
of HbA1c were associated with increasing concentrations
of small HDL particles. Such relationship was also
observed in diabetic females with African Surinamese
background. Small HDL particles are the most efﬁcient
particle in ABCA1-mediated cholesterol efﬂux45. We
hypothesized that subjects with African background
might have impaired cholesterol efﬂux capacity to small
HDL particles. In order to compensate this impairment, a
larger number of small HDL particles was produced.
Given that increasing HbA1c correlated with increasing
acetoacetate in diabetic subjects with African background,
we further hypothesized that the impaired ABCA1-
mediated cholesterol efﬂux was induced by acetoacetate.
ABCA1-mediated cholesterol efﬂux and LDLr-mediated
cholesterol uptake together determine overall accumula-
tion of intracellular cholesterol. To address the question if
LDLr-mediated cholesterol uptake plays a role in excess
burden of T2DM in subjects with African background, we
assessed the associations between HbA1c and apolipo-
protein B containing lipoproteins. There are two types of
apolipoprotein B containing lipoproteins, TG-rich and
cholesterol-rich lipoproteins.
We ﬁrst focused on the TG-rich lipoproteins that ran-
ged from extremely large to very small VLDL particles.
Like what we observed with the amino acids, associations
of HbA1c with TG-rich lipoproteins were stronger in
prediabetic subjects than in diabetic subjects, and were
stronger in subjects with European background than in
subjects with African backgrounds. Based on these
observations, we ruled out the possibility that excess
burden of T2DM in subjects with African background was
due to excess supply of TG-rich lipoproteins.
Cholesterol-rich lipoproteins included IDL, large,
medium and small LDL particles. We observed that
increasing concentrations of HbA1c were associated with
increasing concentrations of small LDL particles in dia-
betic subjects with African Surinamese and Ghanaian
background, but were not associated with small LDL
particles in diabetic subjects with European background.
It was shown that excess uptake of cholesterol mediated
by LDL receptor leads to cholesterol accumulation in islet
and beta cell dysfunction29.
Overall, we observed that an increase in HbA1c was
associated with more small HDL particles and more small
LDL particles in subjects with African background, indi-
cating impaired ABCA1-mediated cholesterol efﬂux
capacity as well as excess LDLr-mediated cholesterol
accumulation. These metabolic abnormalities might be
linked to the excess burden of T2DM in subjects with
African background. Future research is needed to test our
hypothesis.
Strength and limitation
A strength of this study is the use of Bayesian imputa-
tion to take care of missing observations in both depen-
dent and independent variables. Dropping cases with
missing data is the default setting used by many data
analysis programs. However, this is almost never appro-
priate because the dropped cases can bias the results. The
advantage of Bayesian imputation is that it does not
generate one or a few imputed values but a whole pos-
terior distribution for each missing observation.
One limitation of this study is that the three ethnic
groups were from two different cohort studies, with dif-
ferent time of sampling and measurement. As a con-
sequence, we cannot directly compare metabolite
variables between ethnic groups but did run association
analyses within each ethnic group. Another limitation is
that we did not have information on medication use, diet
and physical activity of participants. To partially account
for the impact, we used BMI as an extra covariate in our
statistical model.
In conclusion, subjects with Ghanaian and African
Surinamese background showed different associations of
HbA1c with circulating acetoacetate, small HDL particles
and small LDL particles compared to Dutch with Eur-
opean background. These metabolic abnormalities sug-
gested that the excess burden of T2DM in subjects with
African background may be due to impaired cholesterol
efﬂux capacity and abnormal cholesterol uptake.
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